Investing Profile

Albert Cha

InvestorVC
Managing Partner at Frazier Healthcare Partners
Photo of Albert Cha, Managing Partner at Frazier Healthcare Partners
cb
$100K - $5.0M
$1.5M
23
CompanyStageDateRound SizeTotal Raised
Scorpion Therapeutics
Series CJul 2024$150M
$420M
Co-investors: Paulina Hill (Polaris Partners), Arjun Goyal (Vida Ventures), Jean-François Formela (Atlas Venture)
Egetis Therapeutics AB
Post Ipo EquityOct 2023$16M
$16M
Silence Therapeutics
Post Ipo EquityNov 2021$20M
$20M
Olema Oncology
Series COct 2020$85M
$85M
AirXpanders
Post Ipo EquitySep 2018$15M
Series ESep 2014$1M
Series EJun 2013$9M
Series DApr 2012$11M
Series DJan 2012$10M
$46M
Bristol-Myers Squibb
Post Ipo EquityFeb 2017$80M
$80M
Co-investors: Eric Aguiar (Aisling Capital), Peter Kolchinsky (RA Capital), Gregory Bailey
Aclaris Therapeutics
Series CSep 2015$40M
Series BOct 2014$21M
Series AOct 2012$21M
$82M
Co-investors: Ketan Patel (F-Prime Capital Partners)
Sierra Oncology
Series DApr 2014$60M
$60M
Co-investors: Peter Thompson (OrbiMed), James N. Topper (Frazier Healthcare Partners)